IMSVISUAL Symposium at ACTRIMS Forum 2019

It is our pleasure to invite you to our IMSVISUAL symposium at ACTRIMS Forum 2019 (being held in Dallas, Texas, February 28 – March 2), to discuss updates on vision research in multiple sclerosis and related disorders. For the third consecutive year we are fortunate to have secured ACTRIMS as our sponsor.

The symposium, integrated into the ACTRIMS program and CME accredited, will take place on Thursday, February 28th from 12:30pm – 1:45pm. Please see below the confirmed agenda for talks/speakers during the session. This symposium/session is open to all attendees of the ACTRIMS Forum 2019.

I think this will be an exciting symposium with presentations from
several groups representing existing IMSVISUAL member sites from
around the world.

We look forward to seeing you all in Dallas!

IMSVISUAL symposium at the ACTRIMS Forum 2019, Thursday, February 28th

Session Chairs: Laura Balcer, NYU Langone Health and Elena Martínez-Laspiscina, Hospital Clínic de Barcelona

Symposium Schedule

1: “Is there progressive retinal damage in neuromyelitis optica spectrum disorders?”
Friedemann Paul, NeuroCure Clinical Research Center

2: “Smartphone Suite of Visual Tests in Multiple Sclerosis”
Randy Kardon, University of Iowa Health Care

3: “Corneal Confocal Microscopy: “A rapid non-invasive technique to image neurodegeneration”
Ioannis Petropoulos, Weill Cornell Medicine – Qatar

4: “Dynamics of retinal layer atrophy in normal aging and multiple sclerosis”
Elias Sotirchos, Johns Hopkins University

5: “Retinal imaging in EAE for translational neuroprotection studies”
Philipp Albrecht, Heinrich-Heine-Universität Düsseldorf

Slide decks for IMSVISUAL talks at ACTRIMS 2017

Thank you all for attending the IMSVISUAL meeting at ACTRIMS 2017! Here are the slide decks:

Thank you for joining our ECTRIMS 2016 meeting

Dear attendees,

on behalf of IMSVISUAL I want to thank you all for joining our meeting!

Many scientific talks were fascinating and - at least for me - a highlight of the conference. I was especially intrigued by the substantial in-depth discussions, which followed every talk, a format/chance I haven't seen in years.

Please find below the presenters' slide decks as much as we can publish them. Many decks contained unpublished data, which needed to be removed. I will update the links as the slides become available from the speakers.


Alexander Brandt

Slides and Documents

  1. Brian FernandezHeidelberg Engineering
  2. Chis ModyOCTA
  3. Ari Green - Clemastine study
  4. Raj Kapoor - Visual Outcomes in the Phenytoin Trial
  5. Kathryn Fitzgerald - The GWAS x Retinal Degeneration Study
  6. Elena H. Martínez-Lapiscina - IMSVISUAL Project Proposal: AON natural history study
  7. Alexander Brandt - Retinal pathology in antibody mediated diseases (the slides contained data from 3 studies, two of which are unpublished as of now. Download links will be updated as studies become published. NMDA Study, MOG Study (in press), NMOSD Study (in preparation)

Invitation for Evening Symposium at ECTRIMS

Dear Colleagues,

It is our pleasure to invite you to our semi-annual IMSVISUAL symposium to discuss updates on vision research in multiple sclerosis. This year at ECTRIMS we are fortunate to have secured Heidelberg engineering as our sponsor. The event will take place on Friday September 16th from 5-8 PM in the Excel Centre. There will be food and beverages.
Space is limited to 48 so we kindly ask that you register using the link below only if you plan to attend.

I think this will be an exciting meeting with presentations from several groups representing existing IMSVISUAL member sites from around the world. There should be ample time for discussion and establishing future collaborations.

We look forward to seeing you there.

Peter Calabresi, Friedemann Paul, Laura Balcer and Pablo Villoslada (board of directors)
Alex Brandt, Rachel Nolan, Elena Hernandez-Martinez and Shiv Saidha (working group committee)

Meeting in Vancouver at AAN 2016

IMSVISUAL will meet at the AAN 2016 in Vancouver.

Wednesday, April 20, 2016 5:00 PM - 6:30 PM

Prince of Wales Room - Hyatt Regency Vancouver
655 Burrard Street, Vancouver, V6C 2R7 (map below)


  1. Welcome
  2. Mission statement
  3. Review of infrastructure and personnel, member sites
  4. Website and survey results
  5. Project review committee and call for proposals plan
  6. Subcommittees: (Clinical Use, Pediatrics, MS & Related Disorders, Electrophysiology, MRI, Genetics)
  7. Initial papers in press
  8. Open discussion
  9. Adjournment

Please contact with any questions.

Meeting in Barcelona at ECTRIMS 2015

The IMSVISUAL consortium invites you to our meeting at ECTRIMS 2015 in Barcelona.

Friday October 9th from 12 to 2pm

University Pompeu Fabra
Room: 55.410 (Department of Information and Communication)
Tanger, 122-140


  1. Welcome and summary by directors
  2. Membership, organization
  3. Grants and funding
  4. Database, data-sharing and authorship policy
  5. Ongoing projects
  6. New projects (segmentation)
  7. Papers (meta-analysis, APOSTEL)
  8. Next meeting: AAN 2016

The building is on the side of the well-known Agbar Tower. Tram T4 is stopping in the convention center and stops almost in front of this building. It takes only 10 min.

Invitation and Agenda as PDF

EAN 2015 Satellite Symposium in Berlin

The retina as an interface between neurology and ophthalmology

Time: Friday, June 19th 2015

Location: Friedrich-Kopsch-Hörsaal, Waldeyer-Haus, Institute of Anatomy, Charité Campus Mitte

Session 1: Clinical relevance of visual system examination in neurology

14:50 – 15:00: Welcome
Friedemann Paul (Berlin, DE) & Alexander U. Brandt (Berlin, DE)
Alexander U. Brandt (Berlin, DE) & Pablo Villoslada (Barcelona, ES)

15:00 – 15:30 Key Note: The Afferent Visual Pathway: Defining Structural-Functional Correlations in Central Nervous System Disorders
Fiona Costello (Calgary, CA)

15:30 – 15:45 Clinical neurophysiology of the visual system in multiple sclerosis
Letizia Leocani (Milano, IT)

15:45 – 16:00 Erythropoietin treatment in Optic Neuritis – the TONE trial
Wolf Lagrèze (Freiburg, DE)

16:00 – 16:15 To OCT or not to OCT – is optical coherence tomography ready for routine application in multiple sclerosis?
Axel Petzold (Amsterdam, NL)

16:15 – 16:30 Break
Coffee and Snacks

Session 2: Current research in retinal imaging in multiple sclerosis

Wolf Lagrèze (Freiburg, DE) & Friedemann Paul (Berlin, Germany)

16:30 – 17:00 Key Note: The Role of the Visual System in Monitoring Neurodegeneration: Lessons from the MS Model
Peter Calabresi (Baltimore, US)

17:00 – 17:15 Defining disease heterogeneity in multiple sclerosis with the help of OCT and MRI
Sven Schippling (Zürich, CH)

17:15 – 17:30 Implementing Visual Outcomes in Clinical Trials
Alexander U. Brandt (Berlin, DE)

17:30 – 17:45 Next Generation Retinal Imaging
Ari Green (San Francisco, US)

17:45 – 18:00: Farewell
Friedemann Paul (Berlin, DE) & Alexander U. Brandt (Berlin, DE)


Flyer EAN 2015 Satellite Symposium